Synthesis and Evaluation of a Prodrug of 5-aminosalicylic Acid for the Treatment of Ulcerative Colitis

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2020 Mar 6

PMID 32133064

Citations 9

Authors

Yan Yan

Fengling Ren

Pengchong Wang

Ying Sun

Jianfeng Xing

Affiliations

Soon will be listed here.

Abstract

Objectives: This study is aimed to design and synthesize a prodrug of 5-aminosalicylic acid and evaluate its ameliorative effect on experimental ulcerative colitis (UC).

Materials And Methods: 5-Aminosalicylic acid-alanine (5-ASA-ALA) was synthesized and characterized. Its stability study was conducted in rat plasma and in the gastrointestinal tract environment, its transport characteristic was assessed using the Caco-2 cells. Its colon-targeting property was evaluated by the pharmacokinetic study, and incubation studies. A series of indicators were used to investigate its therapeutic effect on experimental colitis, including the survival rate and body weight of mice, the disease activity index (DAI), the colonic damage score and colon index, the myeloperoxidase (MPO) activity and the levels of malondialdehyde (MDA), total superoxide dismutase (SOD), glutathione (GSH) and glutathione peroxidase (GSH-Px) in colonic tissues.

Results: 5-ASA-ALA was barely absorbed in the Caco-2 monolayer or into the rat blood. It was remarkably stable when incubated in the upper gastrointestinal tract, while gradually hydrolyzed in the colon of rats. When orally administered to mice, 5-ASA-ALA had significantly greater therapeutic effect on colitis than the positive control.

Conclusion: 5-ASA-ALA is demonstrated to be a promising oral colon-targeting prodrug of 5-ASA and has potential application in UC treatment.

Citing Articles

Network pharmacology and experimental verification in vivo reveal the mechanism of Zhushao Granules against ulcerative colitis.

Gong B, Zhang C, Hu S, Zhang X, Zou H, Li J Biol Proced Online. 2025; 27(1):7.

PMID: 39953430 PMC: 11827476. DOI: 10.1186/s12575-025-00268-3.

Application of Chinese Medicine in Treatment of Ulcerative Colitis and Elucidation of Relevant Mechanisms.

Zhu J, Wang H, Aisikaer M, Zhou W, Yang T, Aximujiang K Chin J Integr Med. 2025; .

PMID: 39821880 DOI: 10.1007/s11655-025-3824-y.

A Comprehensive Review of Challenges in Oral Drug Delivery Systems and Recent Advancements in Innovative Design Strategies.

Loke Y, Jayakrishnan A, Mod Razif M, Yee K, Kee P, Goh B Curr Pharm Des. 2024; 31(5):360-376.

PMID: 39390835 DOI: 10.2174/0113816128338560240923073357.

Comparable Toxicity of Surface-Modified TiO Nanoparticles: An In Vivo Experimental Study on Reproductive Toxicity in Rats.

Todorovic A, Bobic K, Veljkovic F, Pejic S, Glumac S, Stankovic S Antioxidants (Basel). 2024; 13(2).

PMID: 38397829 PMC: 10886084. DOI: 10.3390/antiox13020231.

Protective roles of vitamin C and 5-aminosalicylic acid on reproduction in acrylamide intoxicated male mice.

Bhuiyan M, Hossain M, Saha A, Kamrul Islam M, Yeasmin Bari F, Khan M Saudi J Biol Sci. 2023; 30(8):103738.

PMID: 37538350 PMC: 10393805. DOI: 10.1016/j.sjbs.2023.103738.

References

Dhaneshwar S, Chail M, Patil M, Naqvi S, Vadnerkar G . Colon-specific mutual amide prodrugs of 4-aminosalicylic acid for their mitigating effect on experimental colitis in rats. Eur J Med Chem. 2008; 44(1):131-42. DOI: 10.1016/j.ejmech.2008.03.035. View

Kohn J, OKelly T . An ortho-tolidine method for the detection of occult blood in faeces. J Clin Pathol. 1955; 8(3):249-51. PMC: 1023823. DOI: 10.1136/jcp.8.3.249. View

Krawisz J, Sharon P, Stenson W . Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology. 1984; 87(6):1344-50. View

Dringen R . Metabolism and functions of glutathione in brain. Prog Neurobiol. 2000; 62(6):649-71. DOI: 10.1016/s0301-0082(99)00060-x. View

Jilani J, Shomaf M, Alzoubi K . Synthesis and evaluation of mutual azo prodrug of 5-aminosalicylic acid linked to 2-phenylbenzoxazole-2-yl-5-acetic acid in ulcerative colitis. Drug Des Devel Ther. 2013; 7:691-8. PMC: 3749060. DOI: 10.2147/DDDT.S48636. View

Das R, Pal S . Modified hydroxypropyl methyl cellulose: Efficient matrix for controlled release of 5-amino salicylic acid. Int J Biol Macromol. 2015; 77:207-13. DOI: 10.1016/j.ijbiomac.2015.03.015. View

El-Kamel A, Abdel-Aziz A, J Fatani A, El-Subbagh H . Oral colon targeted delivery systems for treatment of inflammatory bowel diseases: synthesis, in vitro and in vivo assessment. Int J Pharm. 2008; 358(1-2):248-55. DOI: 10.1016/j.ijpharm.2008.04.021. View

Xing J, You C, Dong K, Sun J, You H, Dong Y . Ameliorative effects of 3,4-oxo-isopropylidene-shikimic acid on experimental colitis and their mechanisms in rats. Int Immunopharmacol. 2013; 15(3):524-31. DOI: 10.1016/j.intimp.2013.02.008. View

Varshosaz J, Emami J, Tavakoli N, Fassihi A, Minaiyan M, Ahmadi F . Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis. Int J Pharm. 2008; 365(1-2):69-76. DOI: 10.1016/j.ijpharm.2008.08.034. View

10.

Xiao B, Merlin D . Oral colon-specific therapeutic approaches toward treatment of inflammatory bowel disease. Expert Opin Drug Deliv. 2012; 9(11):1393-407. DOI: 10.1517/17425247.2012.730517. View

11.

Del Rio D, Serafini M, Pellegrini N . Selected methodologies to assess oxidative/antioxidant status in vivo: a critical review. Nutr Metab Cardiovasc Dis. 2003; 12(6):343-51. View

12.

Hayyan M, Hashim M, AlNashef I . Superoxide Ion: Generation and Chemical Implications. Chem Rev. 2016; 116(5):3029-85. DOI: 10.1021/acs.chemrev.5b00407. View

13.

Marquez Ruiz J, Kedziora K, OReilly M, Maguire J, Keogh B, Windle H . Azo-reductase activated budesodine prodrugs for colon targeting. Bioorg Med Chem Lett. 2012; 22(24):7573-7. DOI: 10.1016/j.bmcl.2012.10.006. View

14.

Katz S . Update in medical therapy of ulcerative colitis: newer concepts and therapies. J Clin Gastroenterol. 2005; 39(7):557-69. DOI: 10.1097/01.mcg.0000170735.43887.3a. View

15.

Hansawasdi C, Kawabata J . Alpha-glucosidase inhibitory effect of mulberry (Morus alba) leaves on Caco-2. Fitoterapia. 2006; 77(7-8):568-73. DOI: 10.1016/j.fitote.2006.09.003. View

16.

Dhaneshwar S . Colon-specific prodrugs of 4-aminosalicylic acid for inflammatory bowel disease. World J Gastroenterol. 2014; 20(13):3564-71. PMC: 3974523. DOI: 10.3748/wjg.v20.i13.3564. View

17.

Abinusawa A, Tenjarla S . Release of 5-Aminosalicylic Acid (5-ASA) from Mesalamine Formulations at Various pH Levels. Adv Ther. 2015; 32(5):477-84. PMC: 4449368. DOI: 10.1007/s12325-015-0206-4. View

18.

Kunes M, Kvetina J, Kholova D, Bures J, Tlaskalova-Hogenova H, Pavlik M . Absorption kinetics of 5-aminosalicylic acid in rat: influence of indomethacin-induced gastrointestinal lesions and Escherichia Coli Nissle 1917 medication. Neuro Endocrinol Lett. 2011; 32 Suppl 1:46-52. View

19.

Roldo M, Barbu E, Brown J, Laight D, Smart J, Tsibouklis J . Azo compounds in colon-specific drug delivery. Expert Opin Drug Deliv. 2007; 4(5):547-60. DOI: 10.1517/17425247.4.5.547. View

20.

Chen L, Zhou Z, Yang Y, Chen N, Xiang H . Therapeutic effect of imiquimod on dextran sulfate sodium-induced ulcerative colitis in mice. PLoS One. 2017; 12(10):e0186138. PMC: 5648150. DOI: 10.1371/journal.pone.0186138. View